News

Rapidscan Pharma claims Rapiscan is a non-weight based, infusion pump-free pharmacological stress agent available in the UK. Unlike older agents, Rapiscan requires no dose adjustment for varying body

Biota Scientific Management is a wholly subsidiary of an Australia-based anti-infective drug developer, Biota. As part of this 5-year grant funding, the company expects to receive $830,287 in

The contract allows Merck, known as MSD outside the US and Canada, to conduct clinical development and manufacture the product. Merck will also get the rights to commercialize

Earlier, the study was initiated as a randomized double-blind Phase II trial in 202 cat allergy patients, in which those who received four doses of Circassia’s T-cell vaccine

The R&D projects will be led by Affymetrix UK, Aridhia Informatics, IDBS, Life Technologies, Oxford Gene Technology and Source BioScience UK. The funding will also help to improve

Kaprolac Skin Repair & Hydration is a steroid-free treatment for eczema, for topical use, which is designed to treat the most common discomforts such as thickened, dry, itchy

Aurobindo Pharma‘s Ramipril capsules USP 1.25mg, 2.5mg, 5mg and 10mg are generic equivalent to King Pharmaceuticals’ Altace capsules 1.25mg, 2.5mg, 5mg and 10mg. Altace capsules are indicated as

The agreement allows for the joint development and licensing of early stage compounds from Lilly to Synthes for use within orthopedic trauma, spine, craniomaxillofacial and reconstructive areas. The

The biotechnology firm’s Neo-Urinary Conduit is indicated as a treatment for bladder dysfunction requiring incontinent urinary diversion. Orphan drug designation offers Tengion seven years of US marketing exclusivity